Delivery Order SPE2DB24D1021-SPE2DB25FFAPT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,957.42 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-competitive delivery order, with a firm fixed price structure, represents a child contract against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $29,915.39 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes under a firm fixed price contract. The award was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this medical supply delivery order. This delivery order operates as a...
- The Defense Logistics Agency has awarded a delivery order valued at $26,313.07 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The contract does not include a set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of Dupixent 300 mg/2 ml syringes. The fixed-price contract, valued at $13,095.42, has a completion date of September 18, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency awarded a $10,256.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes, with an ultimate completion date of September 2, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $47,704.56 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $7,184.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes, with an ultimate completion date of September 10, 2025. This non-set-aside competitive award is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a single pharmaceutical procurement under the company's broader federal medical supply framework supporting military and veteran healthcare systems....
- The Defense Logistics Agency awarded a $12,212.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 25, 2025. AmerisourceBergen will perform this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $47,754.38. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for ultimate completion by July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill the order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $17,017.67 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's headquarters location...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAPTDelivery Order
The Defense Logistics Agency (DLA) awarded a $13,327.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The award falls within AmerisourceBergen's established role as a critical pharmaceutical vendor for the DLA Medical Supply Chain, supporting military and veteran healthcare systems. The $999.999 billion prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, syringes, and medical supplies across multiple therapeutic domains. AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its extensive portfolio of brand-name and generic pharmaceuticals, positions it as a key supplier for Department of Defense healthcare programs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 9/11/25 |